Vaxil Bio Stock Fundamentals
| VXL Stock | CAD 0.01 0.01 33.33% |
Vaxil Bio fundamentals help investors to digest information that contributes to Vaxil Bio's financial success or failures. It also enables traders to predict the movement of Vaxil Stock. The fundamental analysis module provides a way to measure Vaxil Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vaxil Bio stock.
At this time, Vaxil Bio's Other Operating Expenses is fairly stable compared to the past year. Income Tax Expense is likely to climb to about 13.3 K in 2024, whereas Selling And Marketing Expenses is likely to drop 7,011 in 2024. Vaxil | Select Account or Indicator |
Vaxil Bio Company Return On Equity Analysis
Vaxil Bio's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Vaxil Bio Return On Equity | -0.42 |
Most of Vaxil Bio's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vaxil Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Vaxil Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Vaxil Bio is extremely important. It helps to project a fair market value of Vaxil Stock properly, considering its historical fundamentals such as Return On Equity. Since Vaxil Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vaxil Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vaxil Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Vaxil Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Vaxil Bio has a Return On Equity of -0.4191. This is 98.25% lower than that of the Biotechnology sector and 98.85% lower than that of the Health Care industry. The return on equity for all Canada stocks is 35.19% higher than that of the company.
Vaxil Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vaxil Bio's current stock value. Our valuation model uses many indicators to compare Vaxil Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vaxil Bio competition to find correlations between indicators driving Vaxil Bio's intrinsic value. More Info.Vaxil Bio is rated first in return on equity category among related companies. It is rated first in return on asset category among related companies . At this time, Vaxil Bio's Return On Equity is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Vaxil Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vaxil Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vaxil Bio's earnings, one of the primary drivers of an investment's value.Vaxil Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vaxil Bio's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vaxil Bio could also be used in its relative valuation, which is a method of valuing Vaxil Bio by comparing valuation metrics of similar companies.Vaxil Bio is currently under evaluation in return on equity category among related companies.
Vaxil Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Vaxil Bio from analyzing Vaxil Bio's financial statements. These drivers represent accounts that assess Vaxil Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Vaxil Bio's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 3.1M | 30.5M | 10.2M | 2.7M | 2.5M | 3.8M | |
| Enterprise Value | 3.0M | 29.0M | 8.0M | 1.2M | 1.1M | 1.1M |
Vaxil Fundamentals
| Return On Equity | -0.42 | ||||
| Return On Asset | -0.21 | ||||
| Current Valuation | 1.05 M | ||||
| Shares Outstanding | 136.98 M | ||||
| Shares Owned By Insiders | 8.16 % | ||||
| Shares Owned By Institutions | 0.01 % | ||||
| Number Of Shares Shorted | 15.9 K | ||||
| Price To Earning | (1.40) X | ||||
| Price To Book | 2.39 X | ||||
| EBITDA | (456.5 K) | ||||
| Net Income | (453 K) | ||||
| Cash And Equivalents | 307 K | ||||
| Debt To Equity | 11.20 % | ||||
| Current Ratio | 1.07 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (675 K) | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Beta | -3.58 | ||||
| Market Capitalization | 2.05 M | ||||
| Total Asset | 1.54 M | ||||
| Retained Earnings | (19.1 M) | ||||
| Working Capital | 1.14 M | ||||
| Net Asset | 1.54 M |
About Vaxil Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vaxil Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaxil Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaxil Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 81 K | 96 K | |
| Cost Of Revenue | 1.8 K | 1.7 K | |
| Total Revenue | 0.00 | 0.00 | |
| Stock Based Compensation To Revenue | 0.00 | 0.00 | |
| Sales General And Administrative To Revenue | 0.00 | 0.00 | |
| Research And Ddevelopement To Revenue | 0.00 | 0.00 | |
| Capex To Revenue | 0.00 | 0.00 | |
| Revenue Per Share | 0.00 | 0.00 | |
| Ebit Per Revenue | 0.00 | 0.00 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vaxil Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vaxil Bio's short interest history, or implied volatility extrapolated from Vaxil Bio options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxil Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Vaxil Stock analysis
When running Vaxil Bio's price analysis, check to measure Vaxil Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxil Bio is operating at the current time. Most of Vaxil Bio's value examination focuses on studying past and present price action to predict the probability of Vaxil Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxil Bio's price. Additionally, you may evaluate how the addition of Vaxil Bio to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |